The Week in Review #32
POSITIVE NEWS
PROTEOSTASIS THERAPEUTICS
Cystic Fibrosis
Two days ago, a clinical-stage small firm called Proteostasis Therapeutics (PTI) announced positive preliminary results from ongoing Phase 1 cystic fibrosis studies. The trial involved the firm’s proprietary combination therapy doublet, PTI-808 + PTI-801...
This content is for paid subscribers.
Prohost Letters
October 22, 2018
